Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe.
Brobert G, Ruigomez A, Schink T, Voss A, Herings R, Smits E, Swart KMA, Friberg L, Balabanova Y, Tarenz C, Suzart-Woischnik K, Soriano-Gabarró M, Vora P, Homering M, Dyszynski T, Nagel G, Amaya P, García Rodríguez LA. Brobert G, et al. Among authors: schink t. BMJ Open. 2024 Mar 25;14(3):e081348. doi: 10.1136/bmjopen-2023-081348. BMJ Open. 2024. PMID: 38531587 Free PMC article. Review.
Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice.
García-Rodríguez LA, Wallander MA, Friberg L, Ruigomez A, Schink T, Bezemer I, Herings R, Shakir S, Evans A, Davies M, Suzart-Woischnik K, Vora P, Balabanova Y, Soriano-Gabarró M, Brobert G. García-Rodríguez LA, et al. Among authors: schink t. Expert Opin Drug Saf. 2020 Nov;19(11):1513-1520. doi: 10.1080/14740338.2020.1798928. Epub 2020 Aug 4. Expert Opin Drug Saf. 2020. PMID: 32700977
Safety and effectiveness of rivaroxaban for prevention of stroke in patients with nonvalvular atrial fibrillation: analysis of routine clinical data from four countries.
García Rodríguez LA, Ruigómez A, Schink T, Voss A, Smits E, Swart KMA, Balabanova Y, Suzart-Woischnik K, Brobert G, Herings RMC. García Rodríguez LA, et al. Among authors: schink t. Expert Opin Drug Saf. 2023 Jan-Jun;22(6):493-500. doi: 10.1080/14740338.2023.2181334. Epub 2023 Feb 22. Expert Opin Drug Saf. 2023. PMID: 36795067
Development Of A Collaborative European Pharmacoepidemiologic Post-Authorization Safety Study (Pass) Programme Examining Rivaroxaban Use In Routine Clinical Practice.
Brobert G, García RL, Garbe E, Bezemer ID, Layton D, Friberg L, Suzart-Woischnik K, Alderson J, Winchester C, Herings RM, Jobski K, Schink T, Shakir S, Soriano-Gabarró M, Wallander MA. Brobert G, et al. Among authors: schink t. Value Health. 2014 Nov;17(7):A473-4. doi: 10.1016/j.jval.2014.08.1350. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201360 Free article. No abstract available.
Study Design and Cohort Comparability in a Study of Major Cardiovascular Events in New Users of Prucalopride Versus Polyethylene Glycol 3350.
Fortuny J, Gilsenan A, Cainzos-Achirica M, Cantero OF, Flynn RWV, Garcia-Rodriguez L, Kollhorst B, Karlsson P, Linnér L, MacDonald TM, Plana E, Ruigómez A, Schink T, Ziemiecki R, Andrews EB. Fortuny J, et al. Among authors: schink t. Drug Saf. 2019 Oct;42(10):1167-1177. doi: 10.1007/s40264-019-00836-z. Drug Saf. 2019. PMID: 31134513 Free PMC article.
Use of intravenous iron and risk of anaphylaxis: A multinational observational post-authorisation safety study in Europe.
Fortuny J, von Gersdorff G, Lassalle R, Linder M, Overbeek J, Reinold J, Toft G, Timmer A, Dress J, Blin P, Droz-Perroteau C, Ehrenstein V, Franzoni C, Herings R, Kollhorst B, Moore N, Odsbu I, Perez-Gutthann S, Schink T, Rascher K, Rasouliyan L, Rothman KJ, Saigi-Morgui N, Schaller M, Smits E, Forstner M; Intravenous Iron Consortium; Bénichou J, Bircher AJ, Garbe E, Rampton DS, Gutierrez L. Fortuny J, et al. Among authors: schink t. Pharmacoepidemiol Drug Saf. 2021 Oct;30(10):1447-1457. doi: 10.1002/pds.5319. Epub 2021 Jul 12. Pharmacoepidemiol Drug Saf. 2021. PMID: 34181291 Free PMC article.
Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort Study.
Gilsenan A, Fortuny J, Cainzos-Achirica M, Cantero OF, Flynn RWV, Garcia-Rodriguez L, Harding A, Kollhorst B, Karlsson P, Linnér L, MacDonald TM, Odsbu I, Plana E, Ruigómez A, Schink T, Ziemiecki R, Andrews EB. Gilsenan A, et al. Among authors: schink t. Drug Saf. 2019 Oct;42(10):1179-1190. doi: 10.1007/s40264-019-00835-0. Drug Saf. 2019. PMID: 31134512 Free PMC article.
Adherence and Persistence with Once-Daily vs Twice-Daily Direct Oral Anticoagulants Among Patients with Atrial Fibrillation: Real-World Analyses from the Netherlands, Italy and Germany.
Smits E, Andreotti F, Houben E, Crijns HJGM, Haas S, Spentzouris G, Schink T, Gini R, Bartolini C, Penning-van Beest F, Herings R. Smits E, et al. Among authors: schink t. Drugs Real World Outcomes. 2022 Jun;9(2):199-209. doi: 10.1007/s40801-021-00289-w. Epub 2022 Jan 6. Drugs Real World Outcomes. 2022. PMID: 34993898 Free PMC article.
Prescribing pattern of antipsychotic drugs during the years 1996-2010: a population-based database study in Europe with a focus on torsadogenic drugs.
Oteri A, Mazzaglia G, Pecchioli S, Molokhia M, Ulrichsen SP, Pedersen L, Poluzzi E, De Ponti F, Garbe E, Schink T, Herings R, Bezemer ID, Sturkenboom MC, Trifirò G. Oteri A, et al. Among authors: schink t. Br J Clin Pharmacol. 2016 Aug;82(2):487-97. doi: 10.1111/bcp.12955. Epub 2016 May 18. Br J Clin Pharmacol. 2016. PMID: 27061849 Free PMC article.
108 results